(Q36859215)
Statements
Phase II trial of imatinib mesylate in patients with metastatic melanoma (English)
K B Kim
D W Davis
M L Frazier
D J McConkey
A H Diwan
N E Papadopoulos
A Y Bedikian
M I Ross
J N Cormier
J E Gershenwald
J E Lee
P F Mansfield
L A Billings
C S Ng
C Charnsangavej
M Bar-Eli
M M Johnson
A J Murgo
1 reference